| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/29/2005 | US6969585 Universal collection medium |
| 11/29/2005 | US6969584 Cell; for use as a tool in drug screening |
| 11/29/2005 | US6969528 novel phosphorus-containing dendrimers which are functionalized at the level of the inner layers and which comprise protonated tertiary amines as ends, have particularly advantageous properties as vectors for transferring nucleic acids |
| 11/29/2005 | US6969517 Anticancer agents; genetic engineered fusion protein |
| 11/29/2005 | US6969513 administering a live attenuated bacterial vector vaccine to a patient, wherein the vaccine containing an isolated cell comprising an expression vector, contains a nucleotide sequence encoding a restricted-copy-number origin of replication cassette |
| 11/29/2005 | US6969454 Apparatus for the location and concentration of polar analytes using an alternating electric field |
| 11/29/2005 | CA2326494C Assay for methylation in the gst-pi gene |
| 11/29/2005 | CA2318160C Asymmetric cyanine dye quenchers |
| 11/29/2005 | CA2118329C Isolation, characterization, and use of the human .beta. subunit of the high affinity receptor for immunoglobulin e |
| 11/29/2005 | CA2098696C Alcohol acetyltransferase genes and use thereof |
| 11/25/2005 | CA2468148A1 Virulence and antibiotic resistance array and uses thereof |
| 11/24/2005 | WO2005111238A2 Aptamer-mediated intracellular delivery of therapeutic oligonucleotides |
| 11/24/2005 | WO2005111222A1 Method for expressing biosynthetic pathways and uses thereof |
| 11/24/2005 | WO2005111221A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 11/24/2005 | WO2005111220A2 Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences |
| 11/24/2005 | WO2005111219A1 METHODS AND VECTORS FOR EXPRESSING siRNA |
| 11/24/2005 | WO2005111218A2 Carotenoid biosynthesis inhibitor resistance genes and methods of use in plants |
| 11/24/2005 | WO2005111217A2 Nicotiana nucleic acid molecules and uses thereof |
| 11/24/2005 | WO2005111216A2 Methods for modifying plant characteristics |
| 11/24/2005 | WO2005111215A2 Novel nucleic acid sequences and their use in methods for achieving a pathogenic resistance in plants |
| 11/24/2005 | WO2005111214A1 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities |
| 11/24/2005 | WO2005111213A1 Target gene mimitin of myc |
| 11/24/2005 | WO2005111212A2 Biological bar code |
| 11/24/2005 | WO2005111211A2 Micronas and uses thereof |
| 11/24/2005 | WO2005111210A1 Method for extracting nucleic acid and nucleic acid-extracting apparatus |
| 11/24/2005 | WO2005111209A1 High-speed pcr using high-speed dna polymerase |
| 11/24/2005 | WO2005111208A1 Method of proliferating plasma cell |
| 11/24/2005 | WO2005111199A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 11/24/2005 | WO2005111195A2 Improved prebiotic |
| 11/24/2005 | WO2005111074A1 Modified coagulation factors with enhanced stability and their derivatives |
| 11/24/2005 | WO2005111071A1 Complex containing protein with ligand binding capacity, and method of screening substance capable of binding to protein with ligand binding capacity |
| 11/24/2005 | WO2005111067A1 A novel identified oncogene with kinase-domain (nok) |
| 11/24/2005 | WO2005111060A2 Molecules involved in protein folding and methods op identifying them |
| 11/24/2005 | WO2005111059A2 Process for the reduction of endotoxins |
| 11/24/2005 | WO2005111057A2 Immunostimulatory nucleic acids for inducing il-10 responses |
| 11/24/2005 | WO2005110490A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 11/24/2005 | WO2005110476A1 Method of inhibiting telomerase activity and inhibitor |
| 11/24/2005 | WO2005110475A2 Antibodies |
| 11/24/2005 | WO2005110464A2 Irx5 inhibition as treatment for hyperproliferative disorders |
| 11/24/2005 | WO2005110459A2 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 11/24/2005 | WO2005110338A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | WO2005110068A2 Compositions and methods for control of insect infestations in plants |
| 11/24/2005 | WO2005110067A2 Method and compositions for rna interference |
| 11/24/2005 | WO2005096804A3 Self-processing plants and plant parts |
| 11/24/2005 | WO2005095646A3 Episomal expression system |
| 11/24/2005 | WO2005089929A3 Modified surfaces as solid supports for nucleic acid purification |
| 11/24/2005 | WO2005087931A8 Modified oncolytic viruses |
| 11/24/2005 | WO2005085454A3 Method for improving productivity of plant by chloroplast technology |
| 11/24/2005 | WO2005085449A3 Stomatal guard cell specific promoter |
| 11/24/2005 | WO2005080577A3 Method for modulating gibberellic acid-dependent processes in plants |
| 11/24/2005 | WO2005080431A3 Monoclonal antibodies that specifically bind to folate receptor alpha |
| 11/24/2005 | WO2005079267A3 Methods for protein production |
| 11/24/2005 | WO2005073383A3 HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY |
| 11/24/2005 | WO2005068643A3 Biochemical synthesis of 6-amino caproic acid |
| 11/24/2005 | WO2005067709A3 Chimeric murine model comprising human hepatocytes user for screening compounds |
| 11/24/2005 | WO2005065239A3 Novel recombinant proteins with n-terminal free thiol |
| 11/24/2005 | WO2005052174A3 Lactic acid producing yeast |
| 11/24/2005 | WO2005052145A3 Recombinant alkaliizing bacteria |
| 11/24/2005 | WO2005049795A3 Mammalian cell lines for detecting, monitoring, and optimizing oligonucleotide-mediated chromosomal sequence alteration |
| 11/24/2005 | WO2005047511A3 Bacterial expression of protease inhibitors and variants thereof |
| 11/24/2005 | WO2005046710A3 Tgf-beta binding and supported peptides |
| 11/24/2005 | WO2005046709A3 Tgf - beta binding and supported peptides |
| 11/24/2005 | WO2005033132A3 Igf binding proteins |
| 11/24/2005 | WO2005033094A3 Methods for the production of 3-methylamino-1-(thiene-2-yl)-propane-1-ol |
| 11/24/2005 | WO2004104217A3 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases |
| 11/24/2005 | WO2004092391A3 Metabolic engineering for enhanced production of chitin and chitosan in microorganisms |
| 11/24/2005 | WO2004092379A9 Method for treatment of angiogenic disorders |
| 11/24/2005 | WO2004091525A3 Morpholino imaging and therapy via amplification targeting |
| 11/24/2005 | WO2004078929A3 Materials and methods for identifying genes and/or agents that alter replicative lifespan |
| 11/24/2005 | WO2004042346A3 Methods and compositions for diagnosing and monitoring transplant rejection |
| 11/24/2005 | WO2003073836A3 A stress-responsive promoter from maize |
| 11/24/2005 | US20050262598 Proton transporters and uses in plants |
| 11/24/2005 | US20050262597 Method for increasing transgene expression |
| 11/24/2005 | US20050262596 Embryo preferred promoter and method of using same |
| 11/24/2005 | US20050262595 Promotion of somatic embryogenesis in plants by PGA37 gene expression |
| 11/24/2005 | US20050262592 Expression of plasminogen and microplasminogen in duck weed |
| 11/24/2005 | US20050262591 Fatty acid desaturases and mutant sequences thereof |
| 11/24/2005 | US20050262590 Nucleic acid sequences to proteins involved in tocopherol synthesis |
| 11/24/2005 | US20050262589 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 11/24/2005 | US20050262588 Thioesterase-related nucleic acid sequences and methods of use for the production of plants with modified fatty acid composition |
| 11/24/2005 | US20050262587 Novel Bt toxin receptors from lepidopteran insects and methods of use |
| 11/24/2005 | US20050262586 Low temperature responsive nucleotide sequences and uses thereof |
| 11/24/2005 | US20050262585 Soybean FGAM synthase promoters useful in parasite control |
| 11/24/2005 | US20050262584 Master activators of pathogen responsive genes |
| 11/24/2005 | US20050262583 Clubroot resistant brassica oleracea plants |
| 11/24/2005 | US20050262582 Promoter molecules for use in plants |
| 11/24/2005 | US20050262580 Transgenic mouse with a targeted deletion of Elovl4 gene |
| 11/24/2005 | US20050262579 Novel clock gene promoter |
| 11/24/2005 | US20050262578 Non-human animal models of atherosclerosis and methods of use thereof |
| 11/24/2005 | US20050262577 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 11/24/2005 | US20050261488 Novel human membrane protein and polynucleotides encoding the same |
| 11/24/2005 | US20050261487 Dna molecules encoding ligand-gated ion channels from drosophila melanogaster |
| 11/24/2005 | US20050261486 Compositions and methods for binding agglomeration proteins |
| 11/24/2005 | US20050261485 Method of producing antisense oligonucleotide |
| 11/24/2005 | US20050261483 Genes encoding proteins with pesticidal activity |
| 11/24/2005 | US20050261482 Regulation of human serine-threonine protein kinase |
| 11/24/2005 | US20050261481 Novel human lipase and polynucleotides encoding the same |
| 11/24/2005 | US20050261480 Super humanized antibodies |
| 11/24/2005 | US20050261478 For activating T and/or B cells by aggregating three or more cell surface antigens; the activation signals may result in either immune enhancement or immunosuppression |
| 11/24/2005 | US20050261477 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |